ASCO talks about barriers to cancer treatment, new treatments and other key takeaways

Adam Feuerstein/STAT

Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall Street, and biotechnology. He is co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. Signal’s Adam can be reached at stataf.54.

Matthew Harper discusses medical innovation, both its promise and its perils.

Angus reports on basic research, clinical science and drug development that have the potential to change survival and quality of life for patients, as well as developments that impact the cancer community. You can access Angus.08 on Signal.

Katherine MacPhail is a reporter and editorial events programmer at STAT.

We asked Brian Wolpin, presenter at yesterday’s plenary session on Dallason Rajiv Pancreatic Cancer Research, about the sustained standing ovation that punctuated his remarks.

“Honestly, it was hard to gather myself in that moment and carry on after that. It felt like 20 years of work all fit into 12 minutes,” he told us.

It was a truly memorable ASCO conference. With this newsletter, I bid farewell to Chicago. Thank you once again for taking your valuable time. You can join us for a virtual wrap-up on Wednesday.

STAT+ exclusive story

This article is exclusive to STAT+ subscribers

Subscribe to STAT+ for this article and daily biotech coverage and analysis.

Already have an account? Log in

Individual plan Group plan See all plans

To read the rest of this story, subscribe to STAT+.

Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall Street, and biotechnology. He is co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. Signal’s Adam can be reached at stataf.54.
Senior Writer, Medicine, Event Editorial Director
Matthew Harper discusses medical innovation, both its promise and its perils.
Angus reports on basic research, clinical science and drug development that have the potential to change survival and quality of life for patients, as well as developments that impact the cancer community. You can access Angus.08 on Signal.
reporter, live journalism
Katherine MacPhail is a reporter and editorial events programmer at STAT.